231 related articles for article (PubMed ID: 30234012)
1. Phenotypic Basis for Matrix Stiffness-Dependent Chemoresistance of Breast Cancer Cells to Doxorubicin.
Joyce MH; Lu C; James ER; Hegab R; Allen SC; Suggs LJ; Brock A
Front Oncol; 2018; 8():337. PubMed ID: 30234012
[TBL] [Abstract][Full Text] [Related]
2. Effect of Hydrogel Stiffness on Chemoresistance of Breast Cancer Cells in 3D Culture.
Zeng T; Chen H; Yoshitomi T; Kawazoe N; Yang Y; Chen G
Gels; 2024 Mar; 10(3):. PubMed ID: 38534620
[TBL] [Abstract][Full Text] [Related]
3. Matrix Stiffness-Regulated Growth of Breast Tumor Spheroids and Their Response to Chemotherapy.
Li Y; Khuu N; Prince E; Tao H; Zhang N; Chen Z; Gevorkian A; McGuigan AP; Kumacheva E
Biomacromolecules; 2021 Feb; 22(2):419-429. PubMed ID: 33136364
[TBL] [Abstract][Full Text] [Related]
4. Active tissue stiffness modulation controls valve interstitial cell phenotype and osteogenic potential in 3D culture.
Duan B; Yin Z; Hockaday Kang L; Magin RL; Butcher JT
Acta Biomater; 2016 May; 36():42-54. PubMed ID: 26947381
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix type modulates mechanotransduction of stem cells.
Stanton AE; Tong X; Yang F
Acta Biomater; 2019 Sep; 96():310-320. PubMed ID: 31255664
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins.
Lovitt CJ; Shelper TB; Avery VM
BMC Cancer; 2018 Jan; 18(1):41. PubMed ID: 29304770
[TBL] [Abstract][Full Text] [Related]
7. Mechanomimetic 3D Scaffolds as a Humanized In Vitro Model for Ovarian Cancer.
Paradiso F; Lenna S; Gazze SA; Garcia Parra J; Murphy K; Margarit L; Gonzalez D; Francis L; Taraballi F
Cells; 2022 Feb; 11(5):. PubMed ID: 35269446
[TBL] [Abstract][Full Text] [Related]
8. Patterned photocrosslinking to establish stiffness anisotropies in fibrous 3D hydrogels.
Jagiełło A; Hu Q; Castillo U; Botvinick E
Acta Biomater; 2022 Mar; 141():39-47. PubMed ID: 34971786
[TBL] [Abstract][Full Text] [Related]
9. Chemoprotection Across the Tumor Border: Cancer Cell Response to Doxorubicin Depends on Stromal Fibroblast Ratios and Interstitial Therapeutic Transport.
Logsdon DK; Beeghly GF; Munson JM
Cell Mol Bioeng; 2017 Oct; 10(5):463-481. PubMed ID: 31719872
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional microenvironment confers enhanced sensitivity to doxorubicin by reducing p53-dependent induction of autophagy.
Gomes LR; Vessoni AT; Menck CF
Oncogene; 2015 Oct; 34(42):5329-40. PubMed ID: 25619836
[TBL] [Abstract][Full Text] [Related]
11. Identification of a mechanogenetic link between substrate stiffness and chemotherapeutic response in breast cancer.
Medina SH; Bush B; Cam M; Sevcik E; DelRio FW; Nandy K; Schneider JP
Biomaterials; 2019 May; 202():1-11. PubMed ID: 30818087
[TBL] [Abstract][Full Text] [Related]
12. Role of stiffness and physico-chemical properties of tumour microenvironment on breast cancer cell stemness.
Shah L; Latif A; Williams KJ; Tirella A
Acta Biomater; 2022 Oct; 152():273-289. PubMed ID: 36087866
[TBL] [Abstract][Full Text] [Related]
13. Stromal cell-laden 3D hydrogel microwell arrays as tumor microenvironment model for studying stiffness dependent stromal cell-cancer interactions.
Yue X; Nguyen TD; Zellmer V; Zhang S; Zorlutuna P
Biomaterials; 2018 Jul; 170():37-48. PubMed ID: 29653286
[TBL] [Abstract][Full Text] [Related]
14. ECM Composition and Rheology Regulate Growth, Motility, and Response to Photodynamic Therapy in 3D Models of Pancreatic Ductal Adenocarcinoma.
Cramer GM; Jones DP; El-Hamidi H; Celli JP
Mol Cancer Res; 2017 Jan; 15(1):15-25. PubMed ID: 27671335
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous microenvironmental stiffness regulates pro-metastatic functions of breast cancer cells.
Liu C; Li M; Dong ZX; Jiang D; Li X; Lin S; Chen D; Zou X; Zhang XD; Luker GD
Acta Biomater; 2021 Sep; 131():326-340. PubMed ID: 34246802
[TBL] [Abstract][Full Text] [Related]
16. ECM stiffness-tuned exosomes drive breast cancer motility through thrombospondin-1.
Patwardhan S; Mahadik P; Shetty O; Sen S
Biomaterials; 2021 Dec; 279():121185. PubMed ID: 34808560
[TBL] [Abstract][Full Text] [Related]
17. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.
Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T
Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876
[TBL] [Abstract][Full Text] [Related]
18. A 3D tension bioreactor platform to study the interplay between ECM stiffness and tumor phenotype.
Cassereau L; Miroshnikova YA; Ou G; Lakins J; Weaver VM
J Biotechnol; 2015 Jan; 193():66-9. PubMed ID: 25435379
[TBL] [Abstract][Full Text] [Related]
19. Modelling the disease: H
Buonvino S; Arciero I; Martinelli E; Seliktar D; Melino S
Mater Today Bio; 2023 Dec; 23():100862. PubMed ID: 38046276
[TBL] [Abstract][Full Text] [Related]
20. The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices.
Senthebane DA; Jonker T; Rowe A; Thomford NE; Munro D; Dandara C; Wonkam A; Govender D; Calder B; Soares NC; Blackburn JM; Parker MI; Dzobo K
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30241395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]